We are live on
!
Find out more
NCM
Narwhal Capital Management Portfolio holdings
AUM
$1.45B
Turnover
15.82%
1-Year Est. Return
28.39%
This Fund
S&P 500
This Quarter
Est. Return
+5.25%
1 Year Est. Return
+28.39%
3 Year Est. Return
+93.85%
5 Year Est. Return
+119.75%
10 Year Est. Return
+391.36%
AUM
$435M
AUM Growth
+$31.6M
(+7.8%)
Cap. Flow
+$12.6M
Cap. Flow
% of AUM
2.89%
Top 10 Holdings %
Top 10 Hldgs %
28.37%
Holding
157
New
10
Increased
69
Reduced
42
Closed
10
Avg Time Held
2.8
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.63M |
| 2 |
Abbott
ABT
|
+$2.55M |
| 3 |
Johnson Controls International
JCI
|
+$1.93M |
| 4 |
Apple
AAPL
|
+$1.7M |
| 5 |
Procter & Gamble
PG
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$9.94M |
| 2 |
CVS Health
CVS
|
+$1.86M |
| 3 |
HCA Healthcare
HCA
|
+$1.76M |
| 4 |
Walt Disney
DIS
|
+$1.69M |
| 5 |
CELG
Celgene Corp
CELG
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.35% |
| 2 | Financials | 12.7% |
| 3 | Miscellaneous | 12.65% |
| 4 | Industrials | 10.38% |
| 5 | Healthcare | 10.25% |
Similar funds
NP
BFMH
WIM
SS
DN
SWM
VV
CTC
Narwhal Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Narwhal Capital Management held 157 positions worth $435M, up 7.8% from $403M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Narwhal Capital Management's Q4 2017 filing shows 10 new, 69 increased, 42 reduced and 10 closed positions. Its largest new stake was Abbott: 45,967 shares worth $2.62M. The largest sale was Vulcan Materials, an estimated $9.94M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Miscellaneous.
- Narwhal Capital Management's largest Q4 2017 buy was Abbott: 45,967 shares worth $2.62M.
- Narwhal Capital Management added most to UnitedHealth in Q4 2017, an estimated $2.63M increase.
- Narwhal Capital Management's biggest Q4 2017 reduction was Vulcan Materials, cutting an estimated $9.94M.
- Narwhal Capital Management fully exited Celgene Corp in Q4 2017, selling an estimated $1.29M.
- Narwhal Capital Management's ten largest holdings make up 28% of its $435M portfolio in Q4 2017.
- Narwhal Capital Management opened 10 new positions and closed 10 in Q4 2017.
- Narwhal Capital Management's portfolio value rose 7.8% quarter-over-quarter to $435M.
Based on Narwhal Capital Management's 13F filing for Q4 2017, filed 23 Jan 2018.